SECTOR OF CARE VARIATIONS IN PRESCRIPTIONS OF SGLT2 INHIBITORS (SGLT2I) AND GLP-1 RECEPTOR AGONISTS (GLP-1 RA) IN THE US MILITARY HEALTH SYSTEM (MHS)

被引：0
|
作者：
Nguyen, Julia [1 ]
Nee, Robert [1 ,2 ]
Marneweck, Hava [3 ]
Banaag, Amanda [3 ]
Koehlmoos, Tracey [2 ]
Oliver, James [1 ,2 ]
机构：
[1] Walter Reed Natl Mil Med Ctr, Bethesda, MD 20814 USA
[2] Uniformed Serv Univ Hlth Sci, Bethesda, MD 20814 USA
[3] Henry M Jackson Fdn Advacement Mil Med Inc, Bethesda, MD 20817 USA
来源：
AMERICAN JOURNAL OF KIDNEY DISEASES | 2025年 / 85卷 / 04期
关键词：
D O I：
暂无
中图分类号：
R5 [内科学]; R69 [泌尿科学（泌尿生殖系疾病）];
学科分类号：
1002 ; 100201 ;
摘要：
G-371
引用
收藏
页数：2
相关论文
共 50 条
  • [1] Risk-Benefit of SGLT2 Inhibitors (SGLT2i) vs. GLP-1 Receptor Agonists (GLP-1RA) in Routine Care of Older Adults
    Patorno, Elisabetta
    Kim, Dae H.
    Pawar, Ajinkya
    Schneeweiss, Sebastian
    Glynn, Robert J.
    Munshi, Medha
    Bessette, Lily G.
    Kim, Seoyoung C.
    DIABETES, 2019, 68
  • [2] SGLT2 inhibitors and GLP-1 receptor agonists: the definitive combination?
    Cervantes, Carlos Escobar
    LANCET DIABETES & ENDOCRINOLOGY, 2024, 12 (08): : 507 - 508
  • [3] GLP-1 receptor agonists and SGLT2 inhibitors: a couple at last?
    Nauck, Michael A.
    Meier, Juris J.
    LANCET DIABETES & ENDOCRINOLOGY, 2016, 4 (12): : 963 - 964
  • [4] SGLT2 inhibitors and GLP-1 receptor agonists: a sound combination
    De Block, Christophe
    LANCET DIABETES & ENDOCRINOLOGY, 2018, 6 (05): : 349 - 352
  • [5] SGLT2 inhibitors and GLP-1 receptor agonists: established and emerging indications
    Brown, Emily
    Heerspink, Hiddo J. L.
    Cuthbertson, Daniel J.
    Wilding, John P. H.
    LANCET, 2021, 398 (10296): : 262 - 276
  • [6] Type 1 diabetes: Prescription of GLP-1 receptor agonists and SGLT2 inhibitors
    Simon, Annika
    DIABETOLOGIE UND STOFFWECHSEL, 2025, 20 (01) : 23 - 23
  • [7] USE OF GLP-1 RECEPTOR AGONISTS (GLP1A) AND/OR SGLT-2 INHIBITORS (SGLT2I) IN POPULATIONS WITH NASH OR AT RISK OF NASH IN US CLINICAL PRACTICE
    Lai, Michelle
    Broestl, Jeremy
    Juneja, Kavita
    Milligan, Scott
    Radtchenko, Janna
    Younossi, Zobair M.
    Afdhal, Nezam H.
    GASTROENTEROLOGY, 2020, 158 (06) : S1446 - S1446
  • [8] GLP-1 RA and SGLT2 Inhibitors In Harmony for Organ Protection
    Aroda, Vanita R.
    Billings, Liana K.
    JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY, 2023, 82 (06) : 526 - 528
  • [9] Use of GLP-1 receptor agonists (GLP1A) and/or SGLT-2 inhibitors (SGLT2I) in populations with NASH or at risk of NASH in US clinical practice
    Lai, Michelle
    Broestl, Jeremy
    Juneja, Kavita
    Milligan, Scott
    Radtchenko, Janna
    Younossi, Zobair
    Afdhal, Nezam
    JOURNAL OF HEPATOLOGY, 2020, 73 : S452 - S452
  • [10] GLP-1 receptor agonists in comparison with SGLT-2 inhibitors
    Pavlicek, Vojtech
    DIABETOLOGE, 2020, 16 (05): : 530 - 531
12345